Posts
October 04 2017
Jaguar Health, Inc. announced the closing of their public underwritten offering of common stock in the amount of $4,250,000. EG&S acted as counsel to the placement agent, Maxim Group, LLC.
October 04 2017
Jaguar Health, Inc. announced the closing of its public underwritten offering of common stock in the amount of $4,250,000. EG&S acted as counsel to the underwriter, Maxim Group, LLC.
October 04 2017
Aethlon Medical, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000. EG&S acted as counsel to the Placement Agent.
October 03 2017
The Deal’s exclusive League Table ranking tracks PIPEs that raise at least $1 million between January 1 and September 15, 2017. Ellenoff Grossman & Schole LLP was the top-ranked agent legal counsel with eight placements advised and tied for second, with four placements advised for investor legal counsel.
Click here to read the full report.
October 02 2017
Nacuity Pharmaceuticals, Inc. announced the closing of their private placement of preferred stock and warrants in the amount of $9,422,000 over three closings. EG&S acted as counsel to Maxim Group LLC.
October 02 2017
Rosetta Genomics announced the closing of their PIPE offering in the amount of $2,000,000. EG&S acted as counsel to the Investor.
September 25 2017
China National Heavy Duty Truck Group Co. Ltd. announced that it has acquired 9.9% of UQM Technologies, Inc. (NYSE American: UQM) and has agreed to acquire an additional 24.1% of UQM subject to approval by the U.S. Committee on Foreign Investment in the United States (“CFIUS”). EGS is acting as counsel to CNHTC.
September 22 2017
Inspyr Therapeutics Inc. announced the closing of their Registered Direct offering in the amount of $1,750,000. EG&S acted as counsel to the Placement Agent.